43 research outputs found

    Spline analyses for the relationship between serum phosphorus and risk of incident dementia with serum phosphorus probability distribution histogram represented in gray bars in the background.

    No full text
    <p>Fig 2a: Overall cohort. Fig 2b: Analysis was restricted to cohort participants with serum phosphorus level >2.5 mg/dl. Fig 2c: Analysis was restricted to cohort participants with serum phosphorus level >4.5 mg/dl.</p

    Adjusted associations of improved eGFR slope, and declining eGFR slopes.

    No full text
    <p>Model adjusted for age, race, gender, diabetes mellitus, hypertension, cardiovascular disease, hyperlipidemia, peripheral artery disease, cerebrovascular disease, chronic lung disease, hepatitis C, HIV, dementia, and initial eGFR. Reference group is patients with stable eGFR slope.</p

    Baseline demographic and health characteristics of cohort participants.

    No full text
    Baseline demographic and health characteristics of cohort participants.</p

    Relationship between serum phosphorus (in quintiles) and risk of incident dementia.

    No full text
    Relationship between serum phosphorus (in quintiles) and risk of incident dementia.</p

    Change in kidney function and the risk of death.

    No full text
    <p>Model 1 adjusted for age, race, gender, diabetes mellitus, hypertension, cardiovascular disease, hyperlipidemia, peripheral artery disease, cerebrovascular disease, chronic lung disease, hepatitis C, HIV, dementia and eGFR at time of cohort entry (T0). Reference group is patients with stable kidney function (eGFR slope).</p

    Adjusted associations of trajectory phenotypes.

    No full text
    HIFNT = High Intercept and Fast Negative Trajectory includes trajectory F. HIPT = High Intercept Positive Trajectory and includes trajectory A and B; IIMNT = Intermediate Intercept Mild Negative Trajectory and includes trajectory C, and D; LIFNT = Low Intercept Fast Negative Trajectory and includes trajectory E and G; Model adjusted for age, race, gender, for age, race, gender, diabetes mellitus, hypertension, cardiovascular disease, hyperlipidemia, peripheral artery disease, cerebrovascular disease, chronic lung disease, hepatitis C, HIV, dementia, and eGFR at time of cohort entry (T0). Reference group is IIMNT.</p
    corecore